Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Array BioPharma Inc. - Array BioPharma's Oral p38 Inhibitor Demonstrates Significant Analgesic Benefit and Systemic Anti-Inflammatory Activity
Arthritis - Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
Biogen Idec - Phase IIb Data Published in the Lancet Show That BG-12, Biogen Idec's Novel Oral Compound, Significantly Reduced Brain Lesions in Patients with Multiple Sclerosis
Cytheris - Cytheris Initiates Asian Phase I/IIa Clinical Trial of Interleukin-7 IL-7 as an Immunotherapy in HCV Patients
Breast Cancer - Data on breast cancer published by F. Puglisi and colleagues
Breast Cancer - Studies from X. Pivot and co-researchers in the area of breast cancer published
Cancer - Emory University, Medical Department reports research in cancer
Graft-Versus-Host Disease - Researchers at University of Washington have published new data on graft-versus-host disease
HIV/AIDS - Research from S.N. Joshi and colleagues provide new insights into HIV/AIDS
Lymphoma - New lymphoma findings from C.H. Geisler and co-researchers published
Neoplasms - Study findings from Muenster University provide new insights into neoplasms
Pharmacokinetics - Reports from T. Endo and co-researchers add new data to research in pharmacokinetics
Photocoagulation - Scientists at University of Wisconsin target photocoagulation
Prostate Cancer - Findings from G. Gravis and co-researchers advance knowledge in prostate cancer
Prostate Cancer - New prostate cancer study results from Mayo Clinic described
Von Willebrand Disease - Data from University of Pittsburgh provide new insights into von Willebrand disease
Cancer Therapy - Data on cancer therapy reported by investigators at Institute of Cancer Research
Cancer Therapy - Reports from University of Washington, Fred Hutchinson Cancer Research Center highlight recent research in cancer therapy
Chronic Lymphocytic Leukemia Therapy - Studies in the area of chronic lymphocytic leukemia therapy reported from Mayo Clinic, Division of Hematology
Clinical Trial Research - Study results from University of Texas, M. D. Anderson Cancer Center provide new insights into clinical trial research
Enzyme Research - Investigators at University of Nebraska, Eppley Institute publish new data on enzyme research
Enzyme Research - Studies from Walter Reed Army Institute of Research, Division of Biochemistry yield new information about enzyme research
Hepatocellular Cancer Clinical Trial - Research findings from Bispebjerg University, Division of Gastroenterology update understanding of hepatocellular cancer clinical trial
Lichen Sclerosus Therapy - Research from University of Regensburg in the area of lichen sclerosus therapy published
Neutropenia Therapy - New findings in neutropenia therapy described by J.Y. Blay and co-researchers
Pancreatic Cancer Therapy - New findings reported from Center for Cancer and Blood Disorders describe advances in pancreatic cancer therapy
Pharmacokinetics - Researchers from University Autonoma of Madrid describe findings in pharmacokinetics
Prostate Cancer Risk Factors - Reports from Massachusetts General Hospital, Department of Radiation Oncology advance knowledge in prostate cancer risk factors
Solid Cancer Therapy - Study findings from Memorial Sloan Kettering Cancer Center, Department of Medicine provide new insights into solid cancer therapy
Accentia Biopharmaceuticals, Inc. - Accentia Biopharmaceuticals to Present at Rodman & Renshaw 10th Annual Healthcare Conference; Company Also Reports On NASDAQ Compliance Plan
Allergan, Inc. - Allergan, Inc. and Spectrum Pharmaceuticals, Inc. Announce Collaboration Agreement for Apaziquone EOquin
Allergies - Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
Alvine Pharmaceuticals, Inc. - Alvine Pharmaceuticals Reports Positive Results With ALV003 in Phase 1 Trial of Therapy in Development for Celiac Disease
AmeriStart - Bulgarian CRO Chooses US-Based AmeriStart to Promote Its Phase 1-3 Clinical Research Services to the American Market
Ardea Biosciences, Inc. - Ardea Biosciences Presents Additional Phase 2a and Preclinical Data on its Lead HIV Product Candidate, RDEA806, at the 48th Annual ICAAC/IDSA 46th Annual Meeting
Ardea Biosciences, Inc. - Ardea Biosciences Presents Preclinical Data on its Lead MEK Inhibitor, RDEA119, Demonstrating Synergy with Other Anti-Cancer Agents in Multiple Tumor Types
Ardea Biosciences, Inc. - Ardea Biosciences Presents Preliminary Data from a Phase 1 Study of RDEA594 at the 2008 ACR/ARHP Annual Scientific Meeting
Arthritis - Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis
Breast Cancer - NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
Bristol-Myers Squibb Company - Study Results Demonstrate More Patients With Early Erosive Rheumatoid Arthritis Treated With ORENCIA abatacept and Methotrexate MTX Achieved DAS28 CRP-Defined Remission Compared to MTX Alone
Cancer - SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
Chronic Obstructive Pulmonary Disease - Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI
Drug Development - Savient's Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
Exelixis, Inc. - Exelixis Announces Third Quarter 2008 Financial Results
Genentech, Inc. - Rituxan Data in Patients with Rheumatoid Arthritis to Be Presented at the American College of Rheumatology Annual Scientific Meeting
GPC Biotech AG - GPC Biotech Presents New Pre-Clinical Data on RGB-286638 Broad-Spectrum Kinase Inhibitor at EORTC-NCI-AACR Meeting
Headache and Migraine - Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura
Hepatitis C Virus - Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
HIV/AIDS - Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
HIV/AIDS - Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
ImClone Systems Incorporated - ImClone Announces ERBITUX Commercial Launch in Canada for Advanced Colorectal Cancer
Immunization - VaxInnates Universal Flu Vaccine Candidate Shown Safe and Immunogenic in Phase I Clinical Study
Influenza - BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
Influenza - BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
Inspire Pharmaceuticals, Inc. - Inspire Announces New Data from Denufosol Phase 3 Program at North American Cystic Fibrosis Conference
Macular Degeneration - Potentia Pharmaceuticals to Present ASaP Phase I Clinical Trial Data for POT-4 at the American Academy of Ophthalmology Annual Meeting
Merck & Co., Inc. - New Phase III Study in Previously Untreated HIV Patients Showed Merck's ISENTRESS raltegravir Reduced HIV Viral Load to Undetectable Levels, Comparable to Efavirenz, When Taken in Combination with Other Medicines
NewsRx - NewsRx Launches Politics & Government Titles; Offers Free Global Warming Publication
Onconova Therapeutics, Inc. - Onconova Therapeutics Announces Publication of Positive Phase I Results for Lead Anticancer Compound in Journal of Clinical Oncology
Othera Pharmaceuticals, Inc. - Othera Pharmaceuticals Announces First U.S. Patent Issued On New Class of Compounds to Treat AMD and Other Ophthalmic Diseases
Ovarian Cancer - Sunesis Announces Updated Clinical Data of Voreloxin in Platinum-Resistant Ovarian Cancer
Ovarian Cancer - Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
Parion Sciences, Inc. - Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment
Pfizer Inc - Pfizer to Present Data on New Approaches to Pain and Inflammation Treatment at ACR Meeting
Pharmacokinetics - PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
Phenomix Corporation - Phenomix Initiates Phase 1a Clinical Trial of Hepatitis C Protease Inhibitor PHX1766
Pneumococcal Disease - Phase 3 Data Indicate Investigational 13-valent Vaccine May Broaden Protection Against Pneumoccocal Disease in Children Younger than Two
Pneumonia - Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Poniard Pharmaceuticals, Inc. - Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
Progenics Pharmaceuticals, Inc. - Progenics Reports Positive Interim Phase 2 Results for Two Dosage Forms of Novel HIV Therapy PRO 140
Prostate Cancer - Medivation Announces Presentation of 24-week Clinical Data of Mdv3100 In Castration-resistant Prostate Cancer Patients
Psoriatic Arthritis - One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study
QLT Inc. - QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System
Receptor BioLogix, Inc. - Receptor BioLogix Names Veteran Life Sciences Executive Dale R. Pfost as Chief Executive Officer
Targanta Therapeutics Corporation - Targanta Presents Efficacy and Safety Data for Oritavancin for the Treatment of Gram-Positive Complicated Skin and Skin Structure Infections cSSSI
